-
2025-521884-12-00
5
2026-03-19
First line triple-negative breast cancer (TNBC)
-
2025-522492-28-00
4
2026-03-13
AChR-Ab Seropositive Generalized Myasthenia Gravis, Myasthenia Gravis,
-
2025-521785-10-00
5
2026-03-04
Glioblastoma
-
2025-522553-19-00
10
2026-02-25
Symptomatic genetic and familial dilated cardiomyopathy.
-
2024-516216-16-00
5
2026-02-13
Invasive mold infections caused by Aspergillus spp., Fusarium spp., Lo
-
2024-519068-42-00
10
2026-02-12
Heterozygous Familial Hypercholesterolemia in pediatric patients
-
2025-521558-40-00
5
2026-02-12
Pulmonary Hypertension Associated with Interstitial Lung Disease
-
2025-522170-36-00
5
2026-02-03
Diabetes Mellitus, Type 1
-
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2024-512486-14-00
5
2026-01-22
Short Bowel Syndrome
-
2025-521797-34-00
5
2026-01-20
Diabetes Mellitus, Type 1
-
2023-508995-12-01
4
2025-12-24
Recurrent or metastatic non-small cell lung cancer (NSCLC)
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2024-516253-49-01
4
2025-12-12
advanced/metastatic HER2-positive breast carcinoma
-
2025-521034-28-00
4
2025-12-05
Moderate to Severe Rheumatoid Arthritis (RA)
-
2024-517393-13-00
4
2025-12-02
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
2024-516906-47-00
10
2025-11-28
Locally Advanced or Metastatic Urothelial Carcinoma
-
2025-520623-24-00
7
2025-11-19
MTAP-deleted Solid Tumors
-
2025-521775-31-00
5
2025-11-12
Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutations
-
2025-521315-39-00
1
2025-11-05
Axial spondyloarthritis
-
2024-514974-39-00
5
2025-10-10
Developmental and Epileptic Encephalopathies (DEEs)
-
2024-516188-10-00
6
2025-10-07
Intracerebral haemorrhage